Adhexpharma

Where the EU money came from

Funding by EU programme. Amounts are Adhexpharma's own share of each project, not the project's full budget.

Projects

3 EU-funded projects, newest first. Each links to the official record.

• BUCCAL-PEPPartner

  Development of a multifunctional biomaterial patch for buccal delivery of peptide-analogue treatments

  Horizon Europe · 2023–2026 · Project on CORDIS ↗

  €713ktheir share
• DERMAREPPartner

  Clinical validation and production upscaling of a novel product for healing of Pressure Ulcers, Leg Ulcers and Diabetic Foot Ulcers.

  Horizon 2020 · 2019–2023 · Project on CORDIS ↗

  €525ktheir share
• TA101-GOCLINPartner

  Clinical development of TA-101 for the treatment of rheumatoid arthritis

  FP7 (2007 to 2013) · 2013–2015 · Project on CORDIS ↗

  €9ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

• Danmarks Tekniske UniversitetDenmark · 1 shared project
• University College Dublin, National University of Ireland, DublinIreland · 1 shared project
• Charite - Universitaetsmedizin BerlinGermany · 1 shared project
• Universidade de AveiroPortugal · 1 shared project
• Q-Biologicals NVBelgium · 1 shared project
• Novo Nordisk A/SDenmark · 1 shared project
• Catalyze B.V.Netherlands · 1 shared project
• Biovotec ASNorway · 1 shared project
• Cromsource SRLItaly · 1 shared project
• Technophage Investigacao e Desenvolvimento Em Biotecnologia SAPortugal · 1 shared project
• Sgs Belgium NVBelgium · 1 shared project
• Cambridge Innovation Technologies Consulting LimitedUnited Kingdom · 1 shared project
• ARTES Biotechnology GmbHGermany · 1 shared project
• Amspar BVNetherlands · 1 shared project
• Microcreate BVNetherlands · 1 shared project
• Biovotec Designated Activity CompanyIreland · 1 shared project

Fields it works in

Research fields recorded on its Horizon projects.

• biomaterials
• biomolecules
• diabetes
• metalloids
• proteins
• rheumatology